|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Financing income, net | |||||
| Loss before income taxes | |||||
| Income Tax expenses | |||||
| Net loss for the year | |||||
| Basic loss per Ordinary Share | |||||
| Diluted loss per Ordinary Share | |||||
| Weighted average number of Ordinary Shares outstanding, basic | |||||
| Weighted average number of Ordinary Shares outstanding, diluted | |||||
Loading...